Naomi Aoki | Vice President-Corporate Communications and Investor Relations |
Nancy Simonian | Chief Executive Officer |
David Roth | Chief Medical Officer |
Joe Ferra | Chief Financial Officer |
Eric Olson | Chief Scientific Officer |
Kenneth Atkins | Cowen |
Ted Tenthoff | Piper Jaffray |
Jason Butler | JMP Securities |
Mark Breidenbach | Oppenheimer |
Zegbeh Jallah | Roth Capital |
Good morning, ladies and gentlemen, and welcome to the Q3 2019 Syros Pharmaceuticals, Inc. Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] I would now like to turn the conference over to your host, Ms.